Zoetis

ZTSNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$29.475 B

$71.33 -0.10%

Close of 21 Sept 2026

Revenue

$9.47B

#430 by revenue

Earnings

$2.67B

#175 by earnings

Shares outstanding

413,223,602

Latest filing cover page

P/E ratio

11.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#18Royalty PharmaRPRX$33.6B
#19Alnylam PharmaceuticalsALNY$32.7B
#20ZoetisZTS$29.5B
#21Roivant SciencesROIV$28.2B
#22InsmedINSM$26.4B

What if Zoetis were worth as much as…

Open the what-if tool →

Gold $30.3T

$73,263.13

Per share 1,027× higher

Bitcoin $1.72T

$4,161.92

Per share 58.3× higher

Nvidia $5.48T

$13,261.24

Per share 186× higher

Or at a round number

$50.0B $100.0B $200.0B $500.0B

Where these numbers come from

Share counts and financials for Zoetis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.